Wendy Olsder

724 total citations
8 papers, 25 citations indexed

About

Wendy Olsder is a scholar working on Economics and Econometrics, Pediatrics, Perinatology and Child Health and Hematology. According to data from OpenAlex, Wendy Olsder has authored 8 papers receiving a total of 25 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Economics and Econometrics, 3 papers in Pediatrics, Perinatology and Child Health and 3 papers in Hematology. Recurrent topics in Wendy Olsder's work include Pharmaceutical Economics and Policy (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). Wendy Olsder is often cited by papers focused on Pharmaceutical Economics and Policy (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). Wendy Olsder collaborates with scholars based in Netherlands, United States and France. Wendy Olsder's co-authors include Tugce Martagan, Christopher S. Tang, Ivan Padjen, Simon Stones, Paul Studenic, N. Caeyers, Alessia Alunno, Marios Kouloumas, Laure Gossec and Tanja Stamm and has published in prestigious journals such as Management Science, Annals of the Rheumatic Diseases and Decision Sciences.

In The Last Decade

Wendy Olsder

8 papers receiving 25 citations

Peers

Wendy Olsder

EE

MIS

HEMAT

PPCH

SH

Fiona Hayes United Kingdom

Anna Waldman‐Brown United States

Silvia Appelt Germany

Ana Batista Chile

Arnaud Serret-Larmande France

Chelsea Markowitz South Africa

Li‐An Lin United States

Jennifer De Lurio United Kingdom

Atallah Fahed Alserhan Jordan

Fiona Hayes United Kingdom

Wendy Olsder

5 ×0.6

EE

0 ×0.0

MIS

2 ×0.4

HEMAT

4 ×1.0

PPCH

0 ×0.0

SH

Citations per year, relative to Wendy Olsder Wendy Olsder (= 1×) peers Fiona Hayes

Countries citing papers authored by Wendy Olsder

Since Specialization

Citations

This map shows the geographic impact of Wendy Olsder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Olsder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Olsder more than expected).

Fields of papers citing papers by Wendy Olsder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy Olsder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Olsder. The network helps show where Wendy Olsder may publish in the future.

Co-authorship network of co-authors of Wendy Olsder

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Olsder. A scholar is included among the top collaborators of Wendy Olsder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Olsder. Wendy Olsder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Mease, Philip J., Kevin Winthrop, Wendy Olsder, & Jeffrey R. Curtis. (2022). COVID-19 Update for the GRAPPA 2021 Annual Meeting: Focus on COVID-19 Vaccination. The Journal of Rheumatology. 49(6 Suppl 1). jrheum.211319–jrheum.211319. 1 indexed citations

2.

Olsder, Wendy, Tugce Martagan, & Christopher S. Tang. (2022). Converting a drug from off‐label to on‐label use: Government subsidies and patient welfare. Decision Sciences. 54(6). 579–595. 1 indexed citations

3.

Olsder, Wendy, Tugce Martagan, & Christopher S. Tang. (2022). Improving Access to Rare Disease Treatments: Subsidy, Pricing, and Payment Schemes. Management Science. 69(9). 5256–5274. 10 indexed citations

4.

Mosor, Erika, Paul Studenic, Alessia Alunno, et al.. (2021). Young people’s perspectives on patient-reported outcome measures in inflammatory arthritis: results of a multicentre European qualitative study from a EULAR task force. RMD Open. 7(1). e001517–e001517. 8 indexed citations

5.

Leung, Ying Ying, Т. В. Коротаева, Liliana Candia, et al.. (2021). AB0531 THERAPIES FOR PERIPHERAL JOINT INVOLVEMENT IN PSORIATIC ARTHRITIS: A SYSTEMATIC LITERATURE REVIEW. Annals of the Rheumatic Diseases. 80. 1296–1297. 1 indexed citations

6.

Olsder, Wendy, Tugce Martagan, & Christopher S. Tang. (2020). Converting a Drug From Off-Label to On-Label Use: Government Subsidies and Patient Welfare. SSRN Electronic Journal. 1 indexed citations

7.

Olsder, Wendy, Tugce Martagan, & Christopher S. Tang. (2019). Improving Access to Rare Disease Treatments: Optimal Subsidies, Pricing, and Payment. SSRN Electronic Journal. 2 indexed citations

8.

Schoemaker, Casper, et al.. (2018). OP0210-PARE Dutch juvenile idiopathic arthritis patients, carers and clinicians creating a research agenda together following the james lind alliance method. Annals of the Rheumatic Diseases. 77. 154–154. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact